New Jersey · 2026-2027 Regular Session · Bill

S 4089: Requires health insurance carriers to cover genetic testing after diagnosis of pancreatic cancer.

In committee Last action May 4, 2026: Introduced in the Senate, Referred to Senate Commerce Committee

Plain-language summary

S 4089 is a bill introduced in the New Jersey Senate on May 4, 2026. According to its official title, it concerns: Requires health insurance carriers to cover genetic testing after diagnosis of pancreatic cancer. Primary sponsor: Raj Mukherji (Democratic), Joe Vitale (Democratic). Most recent recorded action (May 4, 2026): Introduced in the Senate, Referred to Senate Commerce Committee.

Sponsors

Primary sponsors: Raj Mukherji (Democratic); Joe Vitale (Democratic).